Eventide Asset Management - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,649,237
-57.5%
34,047
-69.9%
0.03%
-82.6%
Q4 2018$3,878,000
-66.2%
113,000
-53.7%
0.17%
-59.1%
Q3 2018$11,468,000
+398.6%
244,000
+257.8%
0.42%
+343.2%
Q2 2018$2,300,000
+24.7%
68,2000.0%0.10%
+10.5%
Q1 2018$1,845,000
+62.1%
68,2000.0%0.09%
+45.8%
Q4 2017$1,138,000
-16.6%
68,2000.0%0.06%
-23.4%
Q3 2017$1,365,00068,2000.08%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders